News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Silo Pharma Expands Collaboration with Sever Pharma for Novel Ketamine Implant Therapeutic
Friday, August 16, 2024Silo Pharma Inc a developmentalstage biopharmaceutical company specializing in novel drug formulations and delivery systems for traditional and psychedelic therapies today announced a new agreement with Sever Pharma Solutions This collaboration focus...
Certara Launches Phoenix™ Version 8.5 Drug Development Software
Friday, August 16, 2024Certara Inc a global leader in modelinformed drug development today announced the launch of Phoenix version Phoenix is the pharmaceutical industrys gold standard in pharmacokinetic pharmacodynamic PKPD and toxicokinetic modeling and simulation soft...
Bavarian Nordic Announces FDA Acceptance and Priority Review of the BLA for its Chikungunya Vaccine
Wednesday, August 14, 2024Bavarian Nordic AS announced that the US Food and Drug Administration FDA has accepted and granted Priority Review for the Biologics License Application BLA for CHIKV VLP the Companys vaccine candidate for immunization to prevent disease caused
Insignis Therapeutics Receives FDA Fast Track Designation for IN-001 for Anaphylaxis Treatment
Wednesday, August 14, 2024Insignis Therapeutics a pharmaceutical company focused on developing innovative allergy and anaphylaxis treatments is pleased to announce that the US Food and Drug Administration FDA has granted Fast Track designation for its investigational drug IN...
Blue Earth Therapeutics Ltd Expands Partnership with Seibersdorf Labor GmbH to Include Manufacturing of Therapeutic Radiopharmaceutical 225Ac-rhPSMA-10.1
Tuesday, August 13, 2024Blue Earth Therapeutics Ltd a Bracco company and a rising leader in innovative nextgeneration therapeutic radiopharmaceuticals has announced the expansion of its manufacturing agreements with Seibersdorf Labor GmbH This partnership now includes the p...
Persist AI and Nivagen Announce Collaboration on AI-Driven Manufacturing Process for Long-Acting Injectables
Tuesday, August 13, 2024Persist AI and Nivagen have announced a collaboration to codevelop a nextgeneration manufacturing process for longacting injectable LAI drugs using Persists AIbased formulation technology and Nivagens manufacturing capabilities The collaboration aims...
IASO Bio Gains U.S. FDA Approval for Investigational New Drug Application of Equecabtagene Autoleucel for Two New Autoimmune Disease Indications
Monday, August 12, 2024IASO Biotherapeutics a biopharmaceutical company dedicated to discovering developing manufacturing and commercializing innovative cell therapy and antibody products today announced that the investigational new drug IND application
Recursion and Exscientia Enter Agreement to Establish a Global Leader in Technology-Driven Drug Discovery with Comprehensive End-to-End Capabilities
Friday, August 09, 2024Recursion and Exscientia plc announced the companies have entered into a definitive agreement combining Recursion a leading clinical stage technologyenabled biotech company decoding biology to industrialize drug discovery with Exscientia a technology...
Pharmacosmos Group to Acquire G1 Therapeutics
Thursday, August 08, 2024G Therapeutics Inc a commercialstage oncology company focused on delivering nextgeneration therapies that improve the lives of those affected by cancer and Pharmacosmos AS a leader in the development of innovative treatments for patients suffering fr...
Bavarian Nordic Secures $156.8 Million from U.S. Government for Expanded Smallpox/Mpox Vaccine Production
Thursday, August 08, 2024Bavarian Nordic AS announced it has received a new order worth USD million from the Biomedical Advanced Research and Development Authority BARDA part of the Administration for Strategic Preparedness and Response within the US
